[1] KONG M, TANG Y, TONG F, et al. The analgesic efficacy of pericapsular nerve group block in patients with intertrochanteric femur fracture: a randomized controlled trial[J]. PLoS One, 2022,17(10):e0275793. [2] POLAT G, BAYRAM S, GÖKÇEOĠLU Y S, et al. The effect of bone morphology on fracture type and treatment result in patients with intertrochanteric femur fracture aged over 65 year[J]. Ulus Travma Acil Cerrahi Derg, 2022,28(12):1731-1738. [3] SING C W, LIN T C, BARTHOLOMEW S, et al. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality[J]. J Bone Miner Res, 2023,38(8):1064-1075. [4] ABU SHELBAYEH O, ARROUM T, MORRIS S, et al. PGC-1α is a master regulator of mitochondrial lifecycle and ROS stress response[J]. Antioxidants: Basel, 2023,12(5):1075. [5] LI Y, FU G, GONG Y, et al. BMP-2 promotes osteogenic differentiation of mesenchymal stem cells by enhancing mitochondrial activity[J]. J Musculoskelet Neuronal Interact, 2022,22(1):123-131. [6] ZHAO A, XIAO H, ZHU Y, et al. Omentin-1: a newly discovered warrior against metabolic related diseases[J]. Expert Opin Ther Targets, 2022,26(3):275-289. [7] HUANG X, CHEN C, CHEN Y, et al. Omentin-1 alleviate interleukin-1β(IL-1β)-induced nucleus pulposus cells senescence[J]. Bioengineered, 2022,13(5):13849-13859. [8] 蔡振存,王鑫淼,初金泽,等. 老年人A2型股骨粗隆间骨折PFNA和DHS固定疗效比较[J]. 中国老年学杂志, 2016,36(17):4279-4281. [9] YU Y, WANG Y, HOU X, et al. Recent advances in the identification of related factors and preventive strategies of hip fracture[J]. Front Public Health, 2023,11:1006527. [10] ZHANG C, CHEN Z, WANG M, et al. Comparison of clinical outcomes with proximal femoral nail anti-rotation versus dynamic hip screw for unstable intertrochanteric femoral fractures: a meta-analysis[J]. Medicine: Baltimore, 2023,102(6):e32920. [11] CHEN H, FAN W, HE H, et al. PGC-1: a key regulator in bone homeostasis[J]. J Bone Miner Metab, 2022,40(1):1-8. [12] KIM D Y, KO S H. Common regulators of lipid metabolism and bone marrow adiposity in postmenopausal women[J]. Pharmaceuticals: Basel, 2023,16(2):322. [13] 廖宏伟,李学栋,马金锋. 血清CTRP3及PGC-1α表达与创伤性骨折愈合的相关性分析[J]. 中国骨伤, 2022,35(11):1059-1064. [14] TSENG C, HAN Y, LV Z, et al. Glucose-stimulated PGC-1α couples with CBP and Runx2 to mediate intervertebral disc degeneration through transactivation of ADAMTS4/5 in diet-induced obesity mice[J]. Bone, 2023,167:116617. [15] YU M, WANG D, CHEN X, et al. BMSCs-derived mitochondria improve osteoarthritis by ameliorating mitochondrial dysfunction and promoting mitochondrial biogenesis in chondrocytes[J]. Stem Cell Rev Rep, 2022,18(8):3092-3111. [16] SENA C M. Omentin: a key player in glucose homeostasis, atheroprotection, and anti-inflammatory potential for cardiovascular health in obesity and diabetes[J]. Biomedicines, 2024,12(2):284. [17] KARAMPELA I, VALLIANOU NG, TSILINGIRIS D, et al. Diagnostic and prognostic value of serum Omentin-1 in sepsis: a prospective study in critically ill patients[J]. Medicina: Kaunas, 2023,59(5):833. [18] KO C Y, LIN Y Y, ACHUDHAN D, et al. Omentin-1 ameliorates the progress of osteoarthritis by promoting IL-4-dependent anti-inflammatory responses and M2 macrophage polarization[J]. Int J Biol Sci, 2023,19(16):5275-5289. [19] CABRAL V L F, WANG F, PENG X, et al. Omentin-1 promoted proliferation and ameliorated inflammation, apoptosis, and degeneration in human nucleus pulposus cells[J]. Arch Gerontol Geriatr, 2022,102:104748. [20] TANG C, LIANG D, QIU Y, et al. Omentin-1 induces osteoblast viability and differentiation via the TGF-β/Smad signaling pathway in osteoporosis[J]. Mol Med Rep, 2022,25(4):132. |